Skip to main content
. 2005 Aug;49(8):3474–3482. doi: 10.1128/AAC.49.8.3474-3482.2005

TABLE 1.

Inhibitory effect of TAK-220 on HIV-1 envelope-mediated membrane fusion

Compound IC50 (nM)a
JR-FL (R5) HXB2 (X4)
TAK-220 0.42 ± 0.17b >1,000
AMD-3100 >1,000 34 ± 3.6
a

Concentrations of the test compounds required to inhibit membrane fusion by 50%.

b

Assays were performed in triplicate, and data are expressed as the means ± SDs of three separate experiments.